Net profit of Torrent Pharmaceuticals rose 27.05% to Rs 310.00 crore in the quarter ended September 2020 as against Rs 244.00 crore during the previous quarter ended September 2019. Sales rose 0.86% to Rs 1985.00 crore in the quarter ended September 2020 as against Rs 1968.00 crore during the previous quarter ended September 2019.

Powered by Capital Market - Live News

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 October 2020.

Powered by Capital Market - Live News

Torrent Pharmaceuticals Ltd gained for a third straight session today. The stock is quoting at Rs 2840.3, up 1.44% on the day as on 12:59 IST on the NSE. The benchmark NIFTY is up around 1.45% on the day, quoting at 11411.05. The Sensex is at 38661.57, up 1.56%. Torrent Pharmaceuticals Ltd has gained around 2.84% in last one month.

Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has gained around 4.09% in last one month and is currently quoting at 11772.85, up 0.83% on the day. The volume in the stock stood at 4.15 lakh shares today, compared to the daily average of 7.38 lakh shares in last one month.

The benchmark October futures contract for the stock is quoting at Rs 2843, up 1.2% on the day. Torrent Pharmaceuticals Ltd is up 77.65% in last one year as compared to a 0.86% jump in NIFTY and a 59.08% jump in the Nifty Pharma index.

The PE of the stock is 46.73 based on TTM earnings ending June 20.

Powered by Capital Market - Live News

Torrent Pharmaceuticals has received revision in credit ratings from ICRA as under -

Non-Convertible Debentures - ICRA AA, Stable (revised from ICRA AA, placed on rating watch with negative implications)
Commercial Papers - ICRA A1+(revised from ICRA A1+, placed on ratingwatch with negative implications)
Banking facility - ICRA AA, Stable (revised from ICRA AA, placed on rating watch with negative implications)

Powered by Capital Market - Live News